Form 4: Dexcom CFO Jereme Sylvain Sells Shares to Cover Tax Obligations
SEC Form 4
Dexcom's CFO, Jereme Sylvain, sold 11,661 shares of common stock on March 12, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 12, 2024, Jereme M Sylvain, the Executive Vice President and Chief Financial Officer of Dexcom Inc, sold 11,661 shares of Dexcom's common stock.
- The sale was executed at a price of $134.4107 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Sylvain directly owns 85,534 shares of Dexcom, which includes 52,009 unvested restricted stock units.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes on vested RSUs) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and do not necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/08/2022 | 7,060 restricted stock units were granted, vesting through March 8, 2025. |
| 12/15/2021 | 4,384 restricted stock units were granted, vesting through December 15, 2024. |
| 03/08/2023 | 14,512 restricted stock units were granted, vesting through March 8, 2026. |
| 03/08/2024 | 26,053 restricted stock units were granted, vesting through March 8, 2027. |
| 03/12/2024 | Jereme M Sylvain sold 11,661 shares of Dexcom common stock. |
| 03/14/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.